317 related articles for article (PubMed ID: 21098695)
1. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker.
Hofman V; Bonnetaud C; Ilie MI; Vielh P; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Mourad N; Butori C; Selva E; Poudenx M; Sibon S; Kelhef S; Vénissac N; Jais JP; Mouroux J; Molina TJ; Hofman P
Clin Cancer Res; 2011 Feb; 17(4):827-35. PubMed ID: 21098695
[TBL] [Abstract][Full Text] [Related]
2. Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method.
Hofman V; Long E; Ilie M; Bonnetaud C; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Mourad N; Butori C; Selva E; Marquette CH; Poudenx M; Sibon S; Kelhef S; Vénissac N; Jais JP; Mouroux J; Molina TJ; Vielh P; Hofman P
Cytopathology; 2012 Feb; 23(1):30-8. PubMed ID: 21210876
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.
Krebs MG; Sloane R; Priest L; Lancashire L; Hou JM; Greystoke A; Ward TH; Ferraldeschi R; Hughes A; Clack G; Ranson M; Dive C; Blackhall FH
J Clin Oncol; 2011 Apr; 29(12):1556-63. PubMed ID: 21422424
[TBL] [Abstract][Full Text] [Related]
4. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW
Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.
Hofman V; Ilie MI; Long E; Selva E; Bonnetaud C; Molina T; Vénissac N; Mouroux J; Vielh P; Hofman P
Int J Cancer; 2011 Oct; 129(7):1651-60. PubMed ID: 21128227
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
7. Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer.
van der Drift MA; Hol BE; Klaassen CH; Prinsen CF; van Aarssen YA; Donders R; van der Stappen JW; Dekhuijzen PN; van der Heijden HF; Thunnissen FB
Lung Cancer; 2010 May; 68(2):283-7. PubMed ID: 19632736
[TBL] [Abstract][Full Text] [Related]
8. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
[TBL] [Abstract][Full Text] [Related]
12. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications.
Funaki S; Sawabata N; Nakagiri T; Shintani Y; Inoue M; Kadota Y; Minami M; Okumura M
Eur J Cardiothorac Surg; 2011 Aug; 40(2):322-7. PubMed ID: 21215651
[TBL] [Abstract][Full Text] [Related]
13. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
14. [Tumor size and survival in lung cancer, stage IA].
Lyons G; Quadrelli S; Chimondegy D; Iotti A; Silva C
Medicina (B Aires); 2008; 68(1):23-30. PubMed ID: 18416316
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
[TBL] [Abstract][Full Text] [Related]
16. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
[TBL] [Abstract][Full Text] [Related]
18. [Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases].
Battikh MH; Ben Sayah MM; Joobeur S; Rouetbi N; Ben Salem K; Daami M; Maatallah A; Raham W; Farhat C; El Kamel A
Tunis Med; 2004 Sep; 82(9):843-8. PubMed ID: 15693478
[TBL] [Abstract][Full Text] [Related]
19. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
20. Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.
Marchevsky AM; Patel S; Wiley KJ; Stephenson MA; Gondo M; Brown RW; Yi ES; Benedict WF; Anton RC; Cagle PT
Mod Pathol; 1998 Jul; 11(7):618-25. PubMed ID: 9688182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
